Which are the causes of Hyperekplexia?

TL;DR: Hyperekplexia is primarily caused by genetic mutations that impair the body’s ability to process the inhibitory neurotransmitter glycine, leading to an exaggerated startle response and muscle stiffness. While most cases are hereditary, researchers are still investigating the full spectrum of genetic variants and potential secondary factors that contribute to the clinical presentation of this condition.

What are the genetic causes of Hyperekplexia?

The primary cause of Hyperekplexia is a dysfunction in the glycinergic neurotransmission system. In a healthy nervous system, glycine acts like a "brake" on nerve signals. In patients with Hyperekplexia, the "brakes" fail to engage properly. This is typically caused by mutations in genes responsible for the glycine receptor or its associated proteins, such as:

• GLRA1: The most common gene associated with the condition.


• GLRB: Mutations here affect the beta subunit of the glycine receptor.


• SLC6A5: This gene encodes a transporter that helps recycle glycine in the brain.

Is Hyperekplexia hereditary?

Yes, Hyperekplexia is usually inherited. It can follow either an autosomal dominant pattern (where one copy of the mutated gene from a parent is sufficient to cause the condition) or an autosomal recessive pattern (where both parents must carry the mutation). Genetic counseling is essential for families, as the inheritance pattern dictates the risk of passing Hyperekplexia to future generations.

Are there environmental or non-genetic factors?

While Hyperekplexia is fundamentally a genetic disorder, clinical researchers distinguish between the direct cause (the mutation) and risk factors that may exacerbate symptoms. Environmental stimuli, such as sudden loud noises or unexpected physical contact, act as triggers for the startle reflex rather than causes of the disease itself. Currently, there is no strong evidence suggesting that infectious or autoimmune processes cause the primary form of Hyperekplexia, though research into these areas is ongoing to ensure no secondary mimics are overlooked.

What is the current state of research?

Scientists are actively working to map the full genetic landscape of Hyperekplexia. With 56 members currently sharing their experiences on DiseaseMaps.org, we are gaining a better understanding of how different mutations correlate with symptom severity. Future research is focused on developing targeted therapies that can effectively "re-engage" the glycine receptors.

Next steps

• Consult with a clinical geneticist to discuss potential genetic testing.


• Speak with a neurologist to explore symptom management, such as the use of clonazepam.


• Join the community at DiseaseMaps.org to connect with others living with Hyperekplexia.

Medical Disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• Orphanet: Hyperekplexia (ORPHA:439)


• NIH Genetic and Rare Diseases Information Center (GARD)


• Online Mendelian Inheritance in Man (OMIM) - Hyperekplexia entry #149400


• PubMed: Recent clinical reviews on glycinergic receptor pathophysiology